RBC Sciences Financial Statements From 2010 to 2024

0P00007138  CAD 53.29  0.15  0.28%   
RBC Sciences financial statements provide useful quarterly and yearly information to potential RBC sciences biologiques investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on RBC Sciences financial statements helps investors assess RBC Sciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting RBC Sciences' valuation are summarized below:
RBC sciences biologiques does not right now have any fundamental measures for analysis.
Check RBC Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RBC Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . RBC financial statements analysis is a perfect complement when working with RBC Sciences Valuation or Volatility modules.
  
This module can also supplement various RBC Sciences Technical models . Check out the analysis of RBC Sciences Correlation against competitors.

RBC sciences biologiques Fund Net Asset Analysis

RBC Sciences' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current RBC Sciences Net Asset

    
  489.52 M  
Most of RBC Sciences' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RBC sciences biologiques is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, RBC sciences biologiques has a Net Asset of 489.52 M. This is 96.98% lower than that of the RBC Global Asset Management Inc. family and significantly higher than that of the US Equity category. The net asset for all Canada funds is notably lower than that of the firm.

RBC sciences biologiques Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining RBC Sciences's current stock value. Our valuation model uses many indicators to compare RBC Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RBC Sciences competition to find correlations between indicators driving RBC Sciences's intrinsic value. More Info.
RBC sciences biologiques is the top fund in one year return among similar funds. It also is the top fund in three year return among similar funds reporting about  0.58  of Three Year Return per One Year Return. The ratio of One Year Return to Three Year Return for RBC sciences biologiques is roughly  1.73 . Comparative valuation analysis is a catch-all model that can be used if you cannot value RBC Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RBC Sciences' Fund. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About RBC Sciences Financial Statements

RBC Sciences stakeholders use historical fundamental indicators, such as RBC Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although RBC Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in RBC Sciences' assets and liabilities are reflected in the revenues and expenses on RBC Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in RBC sciences biologiques. Please read more on our technical analysis and fundamental analysis pages.
To provide long-term capital growth by investing primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances. RBC Life is traded on Toronto Stock Exchange in Canada.

Pair Trading with RBC Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RBC Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RBC Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with RBC Fund

  0.960P0000OXA6 PHN Multi StylePairCorr
  0.970P000077P2 RBC DividendPairCorr
  0.90P0000716B Mawer Equity APairCorr
  0.970P000071W8 TD Index FundPairCorr
  0.90P0000706A RBC Select BalancedPairCorr
The ability to find closely correlated positions to RBC Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RBC Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RBC Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RBC sciences biologiques to buy it.
The correlation of RBC Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RBC Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RBC sciences biologiques moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RBC Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in RBC Fund

RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
Commodity Directory
Find actively traded commodities issued by global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities